FDA issued a Warning Letter to Namsa on 3/23/2018 as a result of this inspection.
FDA investigators audited the Namsa - Minneapolis, MN, United States facility and issued inspectional observations (via FDA 483) on 17 Nov 2017.
Add To Cart
- Category: Medical Devices & Rad Health
- Inspection end: 17 Nov 2017
- Location: Minneapolis, United States
- FEI: 3010138955